Atlas Trials

A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants

Clinical trial NCT02917733 · COMPLETED

Trial details

NCT number
NCT02917733
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-09-01
Primary completion
2016-11-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.